177 research outputs found
Where Preparedness Meets Opportunity: A Look at Breaking into the Performing Arts Profession
I always knew I wanted to be a performer. My pre-school teacher actually pulled my mom aside one day explaining that I had been singing Jean Val Jeanâs songs from Les MisĂ©rables in the block center. I used to put on shows in my basement, creating costumes, scripts and songs. I would ask my mom to hold a flashlight on me, in lieu of a spotlight, and perform for an audience of teddy bears and stuffed animals. I have always loved performing and always knew that I wanted to pursue it.
Though I loved performing and knew I could only be happy in the performing field, I knew it would be a tough, grueling business. People always speak of how hard âgetting your foot in the doorâ is, and I was not disillusioned. I knew I would have to work hard to make my dream of performing come true. My attempt to break into the performing field and the culmination of four years of hard, determined, disciplined work come to fruition in this years Musical Theater Showcase. On May 15th, 16th, and 17th, I will perform for a company of agents, directors, casting directors, managers, producers and other industry people, displaying my hard work and talent in the hopes of getting noticed or the proverbial âgetting my foot in the door.â Four years of grueling acting work, voice lessons, challenging dance classes and rigorous rehearsals all come to a head in my one-minute showcase package.
Professor Bob Cline, a working casting director and director in New York City, guided the senior class through the necessary steps to prepare for Senior Showcase. His guiding hand and mentoring adequately prepared us to enter the real world of auditioning. One lesson he taught us, and words that will carry with me is that success arises when preparedness meets opportunity. Professor Cline has prepared us; Showcase presents our first opportunity
Recommended from our members
Christ's poverty in antimendicant debate: book VIII of De Pauperie Salvatoris by Richard Fitzralph, andD William Woodford's Defensorium
This thesis comprises a study of two fourteenth-century texts, written as part of the mendicant controversy, book VIII of De pauperie Salvatoris by Richard FitzRalph, Archbishop of Armagh, (c. 1300-1360) and its response, Defensorium Fratrum Mendicantium contra Ricardum Armachanum in Octavo Libello de Pauperie Christi, by the English Franciscan friar, William Woodford (c. 1330-c. 1397). It introduces each theologian, speculating why such significant fourteenth-century thinkers are not more widely known to scholars of this period. It briefly explores how contemporary understandings of the practice of mendicancy have become obscured within a historiography which seems reluctant to turn to the works of the critics of the mendicant friars for information.
Based on a close-reading of each text, the thesis examines FitzRalph's declaration that Christ did not beg, and Woodford's assertion that he did, noting how each theologian uses scripture, the writings of the Church fathers, those of mendicant theologians, and mobilizes arguments from the classical philosopher, Aristotle, to construct their opposing viewpoints. Focussing especially on discussions about poverty, and about the life and activities of Christ, it suggests that information valuable to social historians is located in these texts, where each theologian constructs their own worldview, and rationalizes their position. Of particular interest is FitzRalph's radical fashioning of Christ as a labouring carpenter, and Woodford's construction of a socio-economic and an anti-semitic argument to disprove it.
Finally, the thesis probes the accepted hypothesis that followers of the late fourteenth-century Oxford theologian and heresiarch, John Wyclif, and collectively classified as 'lollards', incorporated wholesale the views of FitzRalph into their own writings. Studying a number of lollard texts, it notes rather a strategic adoption and an equally significant omission, especially concerning FitzRalph's depictions of poverty, and his framing of Christ the carpenter
The Impact of Delayed Treatment of Uncomplicated \u3ci\u3eP. falciparum\u3c/i\u3e Malaria on Progression to Severe Malaria: A Systematic Review and a Pooled Multicentre Individual-Patient Meta-Analysis
BACKGROUND: Delay in receiving treatment for uncomplicated malaria (UM) is often reported to increase the risk of developing severe malaria (SM), but access to treatment remains low in most high-burden areas. Understanding the contribution of treatment delay on progression to severe disease is critical to determine how quickly patients need to receive treatment and to quantify the impact of widely implemented treatment interventions, such as \u27test-and-treat\u27 policies administered by community health workers (CHWs). We conducted a pooled individual-participant meta-analysis to estimate the association between treatment delay and presenting with SM.
METHODS AND FINDINGS: A search using Ovid MEDLINE and Embase was initially conducted to identify studies on severe Plasmodium falciparum malaria that included information on treatment delay, such as fever duration (inception to 22nd September 2017). Studies identified included 5 case-control and 8 other observational clinical studies of SM and UM cases. Risk of bias was assessed using the Newcastle-Ottawa scale, and all studies were ranked as \u27Good\u27, scoring â„7/10. Individual-patient data (IPD) were pooled from 13 studies of 3,989 (94.1% aged \u3c15 years) SM patients and 5,780 (79.6% aged \u3c15 years) UM cases in Benin, Malaysia, Mozambique, Tanzania, The Gambia, Uganda, Yemen, and Zambia. Definitions of SM were standardised across studies to compare treatment delay in patients with UM and different SM phenotypes using age-adjusted mixed-effects regression. The odds of any SM phenotype were significantly higher in children with longer delays between initial symptoms and arrival at the health facility (odds ratio [OR] = 1.33, 95% CI: 1.07-1.64 for a delay of \u3e24 hours versus â€24 hours; p = 0.009). Reported illness duration was a strong predictor of presenting with severe malarial anaemia (SMA) in children, with an OR of 2.79 (95% CI:1.92-4.06; p \u3c 0.001) for a delay of 2-3 days and 5.46 (95% CI: 3.49-8.53; p \u3c 0.001) for a delay of \u3e7 days, compared with receiving treatment within 24 hours from symptom onset. We estimate that 42.8% of childhood SMA cases and 48.5% of adult SMA cases in the study areas would have been averted if all individuals were able to access treatment within the first day of symptom onset, if the association is fully causal. In studies specifically recording onset of nonsevere symptoms, long treatment delay was moderately associated with other SM phenotypes (OR [95% CI] \u3e3 to â€4 days versus â€24 hours: cerebral malaria [CM] = 2.42 [1.24-4.72], p = 0.01; respiratory distress syndrome [RDS] = 4.09 [1.70-9.82], p = 0.002). In addition to unmeasured confounding, which is commonly present in observational studies, a key limitation is that many severe cases and deaths occur outside healthcare facilities in endemic countries, where the effect of delayed or no treatment is difficult to quantify.
CONCLUSIONS: Our results quantify the relationship between rapid access to treatment and reduced risk of severe disease, which was particularly strong for SMA. There was some evidence to suggest that progression to other severe phenotypes may also be prevented by prompt treatment, though the association was not as strong, which may be explained by potential selection bias, sample size issues, or a difference in underlying pathology. These findings may help assess the impact of interventions that improve access to treatment
Miscellany
Art Writings I Believe Roy F. Powell Awardshttps://digitalcommons.georgiasouthern.edu/miscell/1002/thumbnail.jp
The effect on survival of continuing chemotherapy to near death
<p>Abstract</p> <p>Background</p> <p>Overuse of anti-cancer therapy is an important quality-of-care issue. An aggressive approach to treatment can have negative effects on quality of life and cost, but its effect on survival is not well-defined.</p> <p>Methods</p> <p>Using the Surveillance, Epidemiology, and End Results-Medicare database, we identified 7,879 Medicare-enrolled patients aged 65 or older who died after having survived at least 3 months after diagnosis of advanced non-small cell lung cancer (NSCLC) between 1991 and 1999. We used Cox proportional hazards regression analysis, propensity scores, and instrumental variable analysis (IVA) to compare survival among patients who never received chemotherapy (n = 4,345), those who received standard chemotherapy but not within two weeks prior to death (n = 3,235), and those who were still receiving chemotherapy within 14 days of death (n = 299). Geographic variation in the application of chemotherapy was used as the instrument for IVA.</p> <p>Results</p> <p>Receipt of chemotherapy was associated with a 2-month improvement in overall survival. However, based on three different statistical approaches, no additional survival benefit was evident from continuing chemotherapy within 14 days of death. Moreover, patients receiving chemotherapy near the end of life were much less likely to enter hospice (81% versus 51% with no chemotherapy and 52% with standard chemotherapy, P < 0.001), or were more likely to be admitted within only 3 days of death.</p> <p>Conclusions</p> <p>Continuing chemotherapy for advanced NSCLC until very near death is associated with a decreased likelihood of receiving hospice care but not prolonged survival. Oncologists should strive to discontinue chemotherapy as death approaches and encourage patients to enroll in hospice for better end-of-life palliative care.</p
Harnessing peripheral DNA methylation differences in the Alzheimerâs Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease
Background
Alzheimerâs disease (AD) is a chronic progressive neurodegenerative disease impacting an estimated 44 million adults worldwide. The causal pathology of AD (accumulation of amyloid-beta and tau), precedes hallmark symptoms of dementia by more than a decade, necessitating development of early diagnostic markers of disease onset, particularly for new drugs that aim to modify disease processes. To evaluate differentially methylated positions (DMPs) as novel blood-based biomarkers of AD, we used a subset of 653 individuals with peripheral blood (PB) samples in the Alzheimerâs disease Neuroimaging Initiative (ADNI) consortium. The selected cohort of AD, mild cognitive impairment (MCI), and age-matched healthy controls (CN) all had imaging, genetics, transcriptomics, cerebrospinal protein markers, and comprehensive clinical records, providing a rich resource of concurrent multi-omics and phenotypic information on a well-phenotyped subset of ADNI participants.
Results
In this manuscript, we report cross-diagnosis differential peripheral DNA methylation in a cohort of AD, MCI, and age-matched CN individuals with longitudinal DNA methylation measurements. Epigenome-wide association studies (EWAS) were performed using a mixed model with repeated measures over time with a P value cutoff of 1 Ă 10â5 to test contrasts of pairwise differential peripheral methylation in AD vs CN, AD vs MCI, and MCI vs CN. The most highly significant differentially methylated loci also tracked with Mini Mental State Examination (MMSE) scores. Differentially methylated loci were enriched near brain and neurodegeneration-related genes (e.g., BDNF, BIN1, APOC1) validated using the genotype tissue expression project portal (GTex).
Conclusions
Our work shows that peripheral differential methylation between age-matched subjects with AD relative to healthy controls will provide opportunities to further investigate and validate differential methylation as a surrogate of disease. Given the inaccessibility of brain tissue, the PB-associated methylation marks may help identify the stage of disease and progression phenotype, information that would be central to bringing forward successful drugs for AD
John Clare and place
This chapter tackles issues of place in the self-presentation and critical reception of John Clare, and pursues it across a number of axes. The argument centres on the placing of Clare both socio-economically and ânaturallyâ, and limitations exerted upon perceptions of his work. Interrogating criticism this chapter finds a pervasive awkwardness especially in relation to issues of class and labour. It assesses the contemporary âplacingâ of Clare, and seemingly unavoidable insensitivities to labour and poverty in the history industry, place-naming, and polemical ecocriticism. It assesses the ways Clare represents place â in poverty, in buildings, in nature â and, drawing on Michel de Certeau, considers the tactics Clare uses to negotiate his place. It pursues trajectories to âun-placeâ Clare: the flight of fame in Clareâs response to Byron; and the flight of an early poem in songbooks and beyond, across the nineteenth century
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
SARS-CoV-2 infections were rising during early summer 2021 in many countries associated with the Delta variant. We assessed RT-PCR swab-positivity in the REal-time Assessment of Community Transmission-1 (REACT-1) study in England. We observed sustained exponential growth with average doubling time (June-July 2021) of 25 days driven by complete replacement of Alpha variant by Delta, and by high prevalence at younger less-vaccinated ages. Unvaccinated people were three times more likely than double-vaccinated people to test positive. However, after adjusting for age and other variables, vaccine effectiveness for double-vaccinated people was estimated at between ~50% and ~60% during this period in England. Increased social mixing in the presence of Delta had the potential to generate sustained growth in infections, even at high levels of vaccination
- âŠ